Literature DB >> 15073072

Efficacy and safety of antidepressants for children and adolescents.

Jon N Jureidini1, Christopher J Doecke, Peter R Mansfield, Michelle M Haby, David B Menkes, Anne L Tonkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15073072      PMCID： PMC387483          DOI： 10.1136/bmj.328.7444.879

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

2.  Clinician, parent, and child prediction of medication or placebo in double-blind depression study.

Authors:  C W Hughes; G Emslie; R Kowatch; W Weinberg; J Rintelmann; A J Rush
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

3.  Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

Authors:  M B Keller; N D Ryan; M Strober; R G Klein; S P Kutcher; B Birmaher; O R Hagino; H Koplewicz; G A Carlson; G N Clarke; G J Emslie; D Feinberg; B Geller; V Kusumakar; G Papatheodorou; W H Sack; M Sweeney; K D Wagner; E B Weller; N C Winters; R Oakes; J P McCafferty
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-07       Impact factor: 8.829

4.  Psychopharmacological treatment of major depressive disorder in children and adolescents.

Authors:  Christopher K Varley
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

5.  Expectations and the placebo effect in clinical drug trials: why we should not turn a blind eye to unblinding, and other cautionary notes.

Authors:  L C Swartzman; J Burkell
Journal:  Clin Pharmacol Ther       Date:  1998-07       Impact factor: 6.875

6.  Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder.

Authors:  R Harrington; J Whittaker; P Shoebridge; F Campbell
Journal:  BMJ       Date:  1998-05-23

Review 7.  Placebos, drug effects, and study design: a clinician's guide.

Authors:  F M Quitkin
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

Review 8.  Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?

Authors:  Raphael T W Chan; Joseph M Rey; Philip L Hazell
Journal:  Med J Aust       Date:  2002-10-21       Impact factor: 7.738

9.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

Authors:  G J Emslie; A J Rush; W A Weinberg; R A Kowatch; C W Hughes; T Carmody; J Rintelmann
Journal:  Arch Gen Psychiatry       Date:  1997-11

10.  Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.

Authors:  Graham J Emslie; John H Heiligenstein; Karen Dineen Wagner; Sharon L Hoog; Daniel E Ernest; Eileen Brown; Mary Nilsson; Jennie G Jacobson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-10       Impact factor: 8.829
View more
  50 in total

1.  Pediatric psychotropic polypharmacy.

Authors:  Mark R Zonfrillo; Joseph V Penn; Henrietta L Leonard
Journal:  Psychiatry (Edgmont)       Date:  2005-08

2.  fMRI predictors of treatment outcome in pediatric anxiety disorders.

Authors:  Erin B McClure; Abby Adler; Christopher S Monk; Jennifer Cameron; Samantha Smith; Eric E Nelson; Ellen Leibenluft; Monique Ernst; Daniel S Pine
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

Review 3.  Treating depression in children and adolescents: what options now?

Authors:  Christopher K Varley
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Use of stimulants for attention deficit hyperactivity disorder: AGAINST.

Authors:  Harvey Marcovitch
Journal:  BMJ       Date:  2004-10-16

Review 5.  Rethinking childhood depression.

Authors:  Sami Timimi
Journal:  BMJ       Date:  2004-12-11

Review 6.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

Authors:  Karmela Krleza-Jerić; An-Wen Chan; Kay Dickersin; Ida Sim; Jeremy Grimshaw; Christian Gluud
Journal:  BMJ       Date:  2005-04-23

Review 7.  Antidepressants and suicidality.

Authors:  Ulrich Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06       Impact factor: 5.270

8.  Suicide prevention is far more than a psychiatric business.

Authors:  Diego De Leo
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

9.  Use of psychotropic medications in Italian children and adolescents.

Authors:  Antonio Clavenna; Elisa Rossi; Marisa Derosa; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2006-10-07       Impact factor: 3.183

Review 10.  [SSRI and SNRI treatment in children and adolescents. Current views of the benefits and risks].

Authors:  K Holtkamp; B Herpertz-Dahlmann
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.